Literature DB >> 19693792

Cannabis and anxiety: a critical review of the evidence.

José Alexandre Crippa1, Antonio Waldo Zuardi, Rocio Martín-Santos, Sagnik Bhattacharyya, Zerrin Atakan, Philip McGuire, Paolo Fusar-Poli.   

Abstract

BACKGROUND: Anxiety reactions and panic attacks are the acute symptoms most frequently associated with cannabis use. Understanding the relationship between cannabis and anxiety may clarify the mechanism of action of cannabis and the pathophysiology of anxiety. Aims of the present study were to review the nature of the relationship between cannabis use and anxiety, as well as the possible clinical, diagnostic and causal implications.
METHOD: Systematic review of the Medline, PsycLIT and EMBASE literature.
RESULTS: Frequent cannabis users consistently have a high prevalence of anxiety disorders and patients with anxiety disorders have relatively high rates of cannabis use. However, it is unclear if cannabis use increases the risk of developing long-lasting anxiety disorders. Many hypotheses have been proposed in an attempt to explain these relationships, including neurobiological, environmental and social influences.
CONCLUSIONS: The precise relationship between cannabis use and anxiety has yet to be established. Research is needed to fully clarify the mechanisms of such the association.

Entities:  

Mesh:

Year:  2009        PMID: 19693792     DOI: 10.1002/hup.1048

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  113 in total

Review 1.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 2.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

3.  Marijuana use and viral suppression in persons receiving medical care for HIV-infection.

Authors:  Chukwuemeka N Okafor; Zhi Zhou; Larry E Burrell; Natalie E Kelso; Nicole E Whitehead; Jeffery S Harman; Christa L Cook; Robert L Cook
Journal:  Am J Drug Alcohol Abuse       Date:  2016-07-11       Impact factor: 3.829

Review 4.  Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.

Authors:  Simone Tambaro; Marco Bortolato
Journal:  Recent Pat CNS Drug Discov       Date:  2012-04-01

5.  Heterogeneity in the composition of marijuana seized in California.

Authors:  James Richard Burgdorf; Beau Kilmer; Rosalie Liccardo Pacula
Journal:  Drug Alcohol Depend       Date:  2011-02-01       Impact factor: 4.492

6.  Cannabis, a complex plant: different compounds and different effects on individuals.

Authors:  Zerrin Atakan
Journal:  Ther Adv Psychopharmacol       Date:  2012-12

7.  Coping-motivated marijuana use correlates with DSM-5 cannabis use disorder and psychological distress among emerging adults.

Authors:  Ethan Moitra; Paul P Christopher; Bradley J Anderson; Michael D Stein
Journal:  Psychol Addict Behav       Date:  2015-04-27

8.  Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder.

Authors:  Pablo Roitman; Raphael Mechoulam; Rena Cooper-Kazaz; Arieh Shalev
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

9.  Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed.

Authors:  Margaret Haney; A Eden Evins
Journal:  Neuropsychopharmacology       Date:  2015-08-19       Impact factor: 7.853

10.  Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study.

Authors:  Kevin P Hill; Lindsay H Toto; Scott E Lukas; Roger D Weiss; George H Trksak; John M Rodolico; Shelly F Greenfield
Journal:  Am J Addict       Date:  2013 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.